Stay updated on Ralinepag Efficacy in PAH Patients Clinical Trial
Sign up to get notified when there's something new on the Ralinepag Efficacy in PAH Patients Clinical Trial page.

Latest updates to the Ralinepag Efficacy in PAH Patients Clinical Trial page
- Check3 days agoChange DetectedThe site footer revision label updates from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check10 days agoChange DetectedThe clinical trial record for the ralinepag PAH study is displayed with its study details, eligibility criteria, outcomes, participating locations, and related publication, replacing the access-denied page.SummaryDifference100%

- Check17 days agoChange DetectedThe site revision label changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedAn NIH-wide notice about terminology changes appears above the page, and the site revision advances from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check45 days agoChange DetectedThe footer site revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe deletions remove key elements of the study record, including the intervention (ralinepag), related disease terms, trial design details, outcome measures, enrollment timelines, and the locations list. This reduces the contextual information about what the trial is testing, how it is conducted, and where it is taking place.SummaryDifference18%

Stay in the know with updates to Ralinepag Efficacy in PAH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ralinepag Efficacy in PAH Patients Clinical Trial page.